首页> 外文期刊>International Journal of Hematology and Oncology >Acquired Inhibitors to Coagulation Factors in a Male Patient with Systemic Lupus Erythematosus: A Case Report and Review of the Literature
【24h】

Acquired Inhibitors to Coagulation Factors in a Male Patient with Systemic Lupus Erythematosus: A Case Report and Review of the Literature

机译:男性系统性红斑狼疮患者凝血因子的获得性抑制剂:病例报告和文献复习。

获取原文
       

摘要

Acquired coagulation inhibitors are rare but acquired bleeding diathesis caused by autoimmune depletion or dysfunction of coagulation factors can be life-threatening. This occurs most frequently in elderly patients who lack disease associations. Acquired coagulation inhibitors may also arise in association with systemic lupus erythematosus (SLE). The groups of patients who suffer from SLE most frequently are women in their 2nd to 4th decade. In this case, we present a 22-year-old man with systemic lupus erythematosus who developed an acquired inhibitory to factor II, VIII, IX, X and von Willebrand factor (vWF).
机译:获得性凝血抑制剂很少见,但由于自身免疫耗竭或凝血因子功能障碍而导致的获得性血液透析可能危及生命。这在缺乏疾病关联的老年患者中最常见。获得性凝血抑制剂也可能与系统性红斑狼疮(SLE)相关。患有SLE的患者最常见的人群是第二至第四十年的女性。在这种情况下,我们介绍了一名22岁的系统性红斑狼疮患者,该患者对II,VIII,IX,X和von Willebrand因子(vWF)产生了获得性抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号